Serum FSH bioactivity and inhibin levels in patients with gonadotropin secreting and nonfunctioning pituitary adenomas

被引:11
作者
Borgato, S
Persani, L
Romoli, R
Cortelazzi, D
Spada, A
Beck-Peccoz, P
机构
[1] Ist Clin Humanitas, I-20089 Milano, Italy
[2] Univ Milan, Ist Sci Endocrine, Milano, Italy
[3] IRCCS, Osped Maggiore, Milano, Italy
[4] IRCCS, Ist Auxol Italiano, Milano, Italy
关键词
FSH bioactivity; inhibin; NFPA; pituitary tumors;
D O I
10.1007/BF03350773
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been reported that serum FSH bioactivity and inhibin levels can be used as markers of the presence of true gonadotropin-secreting pituitary adenoma (Gn-oma). To verify this hypothesis, we have investigated the bioactivity of FSH and serum inhibin alpha-alpha and alpha-beta A levels in a series of patients with either Gn-oma or nonfunctioning pituitary adenoma (NFPA). Nine patients with Gn-oma (6 men and 3 women), 21 with NFPA (9 men and 12 women) and 30 normal subjects were included in the study. We studied FSH biological activity (FSH-B) by using Sertoli cell aromatase bioassay (SAB) and alpha-alpha and alpha-beta A inhibin levels by two noncompetitive immunometric assays (IEMA). In male patients with Gn-oma, serum immunoreactive FSH (FSH-I) and FSH-B levels ranged from 5.1 to 35.5 U/L and from 8.3 to 48 U/L, respectively, FSH B/l ratio being elevated in 2 (2.5 and 4.1; normal male range: 0.3-1.5), while female patients with Gn-oma had serum FSH-I and FSH-B levels ranging from 43.2 to 162 U/L and from 41.2 to 112.8 U/l, respectively, with a normal FSH B/l ratio. In male patients with NFPA, FSH-I and FSH-B levels ranged from 2.7 to 10.7 U/l and from 2.4 to 11.4 U/l while in females they ranged from 3.4 to 67.9 and from 4.6 to 60.8 U/l, respectively. FSH B/l ratio was elevated in 1 male (3.3) and normal in the remaining patients with NFPA. Serum a-a inhibin levels were normal or low in patients with Gn-oma and NFPA, while a-PA inhibin concentrations were slightly elevated in 1 of 6 postmenopausal women (0.9; normal range <0.7 U/ml). The present study confirms and extends previous reports indicating that male patients with Gn-oma may secrete FSH molecules with increased bioactivity. However, this abnormality was also observed in one male patient with NFPA. Moreover, the measurement of inhibin levels does not appear to be a reliable in vivo marker of pituitary tumors of gonadotroph origin, as it was normal or low in almost all patients with either Gn-oma or NFPA. (J. Endocrinol. Invest. 21: 372-379, 1998) (C)1998, Editrice Kurtis.
引用
收藏
页码:372 / 379
页数:8
相关论文
共 32 条
  • [11] GONADOTROPH ADENOMAS IN MEN PRODUCE BIOLOGICALLY-ACTIVE FOLLICLE-STIMULATING-HORMONE
    GALWAY, AB
    HSUEH, AJW
    DANESHDOOST, L
    ZHOU, MH
    PAVLOU, SN
    SNYDER, PJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (04) : 907 - 912
  • [12] ABNORMAL RESPONSE OF LUTEINIZING-HORMONE BETA-SUBUNIT TO THYROTROPIN-RELEASING-HORMONE IN PATIENTS WITH NONFUNCTIONING PITUITARY-ADENOMA
    GILDELALAMO, P
    PETTERSSON, KSI
    SACCOMANNO, K
    SPADA, A
    FAGLIA, G
    BECKPECCOZ, P
    [J]. CLINICAL ENDOCRINOLOGY, 1994, 41 (05) : 661 - 666
  • [13] SERUM LEVELS OF BETA-SUBUNIT OF CHORIONIC-GONADOTROPIN IN PATIENTS WITH PITUITARY-TUMORS
    GILDELALAMO, P
    SACCOMANNO, K
    LANIA, A
    PETTERSSON, K
    BECKPECCOZ, P
    SPADA, A
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 133 (01) : 33 - 37
  • [14] Measurement of dimeric inhibin B throughout the human menstrual cycle
    Groome, NP
    Illingworth, PJ
    OBrien, M
    Pai, R
    Rodger, FE
    Mather, JP
    McNeilly, AS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (04) : 1401 - 1405
  • [15] Inhibin-B: A likely candidate for the physiologically important form of inhibin in men
    Illingworth, PJ
    Groome, NP
    Byrd, W
    Rainey, WE
    McNeilly, AS
    Mather, JP
    Bremner, WJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (04) : 1321 - 1325
  • [16] GONADOTROPIN-RELEASE BY CLINICALLY NONFUNCTIONING AND GONADOTROPH PITUITARY-ADENOMAS INVIVO AND INVITRO - RELATION TO SEX AND EFFECTS OF THYROTROPIN-RELEASING-HORMONE, GONADOTROPIN-RELEASING HORMONE, AND BROMOCRIPTINE
    KWEKKEBOOM, DJ
    DEJONG, FH
    LAMBERTS, SWJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (06) : 1128 - 1135
  • [17] INHIBIN AND FOLLICLE-STIMULATING-HORMONE LEVELS IN GONADOTROPH ADENOMAS - EVIDENCE OF A POSITIVE CORRELATION WITH TUMOR VOLUME IN MEN
    LAHLOU, N
    LENESTOUR, E
    CHANSON, P
    SERETBEGUE, D
    BOUCHARD, P
    ROGER, M
    WARNET, A
    [J]. CLINICAL ENDOCRINOLOGY, 1993, 38 (03) : 301 - 309
  • [18] THE EFFECTS OF BROMOCRIPTINE, THYROTROPIN-RELEASING-HORMONE, AND GONADOTROPIN-RELEASING-HORMONE ON HORMONE-SECRETION BY GONADOTROPIN-SECRETING PITUITARY-ADENOMAS INVIVO AND INVITRO
    LAMBERTS, SWJ
    VERLEUN, T
    OOSTEROM, R
    HOFLAND, L
    VANGINKEL, LA
    LOEBER, JG
    VANVROONHOVEN, CCJ
    STEFANKO, SZ
    DEJONG, FH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (03) : 524 - 530
  • [19] SERUM BIOACTIVE FOLLICLE-STIMULATING HORMONE-LIKE ACTIVITY INCREASES DURING PREGNANCY
    PADMANABHAN, V
    SONSTEIN, J
    OLTON, PL
    NIPPOLDT, T
    MENON, KMJ
    MARSHALL, JC
    KELCH, RP
    BEITINS, IZ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (05) : 968 - 977
  • [20] AN IMPROVED INVITRO BIOASSAY FOR FOLLICLE-STIMULATING-HORMONE (FSH) - SUITABLE FOR MEASUREMENT OF FSH IN UNEXTRACTED HUMAN-SERUM
    PADMANABHAN, V
    CHAPPEL, SC
    BEITINS, IZ
    [J]. ENDOCRINOLOGY, 1987, 121 (03) : 1089 - 1098